A Day Up For Lineage Cell Therapeutics, Inc.
Tue, Apr 20, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) shot up at $9.79, representing a gain of 27.3%. On Mon, Apr 19, 2021, BTX:NYSEMKT hit a New 2-Week Intraday High of $8.07. The stock got featured on our News Catalysts scanner on Mon, Apr 19, 2021 at 06:23 PM in the 'PRIVATE PLACEMENT' category. From Mon, Apr 05, 2021, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Mar 16, 2021 at $10.28 with a volume of 3M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- HIII (HIII:NASDAQ), 100%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 27.31%
- EBET (EBET:NASDAQ), 24.69%
- Sequential Brands Group, Inc. (SQBG:NASDAQ), 22.04%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 20.6%
- Summer Infant, Inc. (SUMR:NASDAQ), 15.83%
- Kansas City Southern (KSU:NYSE), 15.25%
- PPBT (PPBT:NASDAQ), 13.84%
- Sharps Compliance Corp. (SMED:NASDAQ), 13.53%
- Moxian, Inc. (MOXC:NASDAQ), 13.33%